000 06552cam a22005658i 4500
001 9781003054894
003 FlBoTFG
005 20220509193001.0
006 m o d
007 cr cnu---unuuu
008 201020s2021 onc ob 001 0 eng
040 _aOCoLC-P
_beng
_erda
_cOCoLC-P
020 _a9781003054894
_q(PDF)
020 _a1003054897
020 _a9781000088847
_q(ePub ebook)
020 _a1000088847
020 _a9781000088762
_q(PDF ebook)
020 _a1000088766
020 _a9781000088809
_q(Mobipocket ebook)
020 _a1000088804
020 _z9781771889247
_q(hardcover)
024 8 _a10.1201/9781003054894
_2doi
035 _a(OCoLC)1200842589
035 _a(OCoLC-P)1200842589
050 0 0 _aRM301.25
072 7 _aMED
_x004000
_2bisacsh
072 7 _aMED
_x060000
_2bisacsh
072 7 _aMED
_x071000
_2bisacsh
072 7 _aVXH
_2bicssc
082 0 _a615.1/9
_223
245 0 0 _aApplied pharmaceutical practice and nutraceuticals :
_bnatural product developments /
_cedited by Debarshi Kar Mahapatra, PhD, Cristóbal Noé Aguilar, PhD, A.K. Haghi, PhD.
250 _aFirst edition.
264 1 _aPalm Bay, FL, USA ;
_aBurlington, ON, Canada :
_bApple Academic Press ;
_aBoca Raton, FL, USA ;
_aAbingdon, Oxon, UK :
_bCRC Press ,
_c2021.
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
505 0 _aChalcone (1,3-Diphenyl-2-Propene-1-One) Scaffold Bearing Natural Compounds as Nitric Oxide Inhibitors: Promising Antiedema Agents / Debarshi Kar Mahapatra, Sanjay Kumar Bharti, and Vivek Asati -- Emblicanin-A and Emblicanin-B: Pharmacological and Nano-Pharmacotherapeutic Perspective for Healthcare Applications / Mohamad Taleuzzaman, Debarshi Kar Mahapatra, and Dipak Kumar Gupta -- Recent In-Depth Insights of Nature-Based Anti-Worm Therapeutic Medications: Emerging Herbal Anthelmintics / Ankita Soni, Paras Kothari, and Debarshi Kar Mahapatra -- Insights into the Recent Scientific Evidences of Natural Therapeutic Treasures as Diuretic Agents / Vaibhav Shende, Sameer Hedaoo, and Debarshi Kar Mahapatra -- Reviewing the Available Herbal Resources for Treating Psoriasis: Safe and Alternative Way for Therapeutics / Shruti Dongare, Vaibhav Shende, and Debarshi Kar Mahapatra -- Nutraceuticals and Brain Disorders / Akshada Atul Bakliwal, Vijay Sharadkumar Chudiwal, and Swati Gokul Talele -- 1,3-Diphenyl-2-Propene-1-One-Based Natural Product Antidiabetic Molecules as Inhibitors of Protein Tyrosine Phosphatase-1B (PTP-1B) / Debarshi Kar Mahapatra, Sanjay Kumar Bharti, and Vivek Asati -- Re-Highlighting the Potential Natural Resources for Treating or Managing the Ailments of Gastrointestinal Tract Origin / Vaibhav Shende, Sameer A. Hedaoo, Mojabir Hussen Ansari, Pooja Bhomle, and Debarshi Kar Mahapatra -- Recent Advancements of Curcumin Analogs and Curcumin Formulations in Context to Modern Pharmacotherapeutics Perspectives / Animeshchandra G. M. Haldar, Kanhaiya M. Dadure, and Debarshi Kar Mahapatra -- Emerging Highlights on Natural Prodrug Molecules with Multifarious Therapeutic Perspectives / Mojabir Hussen Ansari, Vaibhav Shende, and Debarshi Kar Mahapatra -- Perspectives of Nature-Oriented Pharmacotherapeutics for the Effectual Management of Hemorrhoidal Symptoms / Taranpreet Kaur Bamrah, Mojabir Hussen Ansari, and Debarshi Kar Mahapatra -- Effect of Light on Transport of Potassium Thiocyanate in Aqueous Solutions / Sónia I. G. Fangaia, Pedro M. G. Nicolau, Fernando A. D. R. A. Guerra,V. M. M. Lobo, and Ana C. F. Ribeiro -- Drug Discovery, Drug-Likeness Screening, and Bioavailability: Development of Drug-Likeness Rule for Natural Products / E. D Ahire, V. N. Sonawane, K. R. Surana, and G. S.Talele -- Biomolecular and Molecular Docking: A Modern Tool in Drug Discovery and Virtual Screening of Natural Products / Khemchand R. Surana, Eknath D. Ahire, Vijayraj N. Sonawane, and Swati G. Talele.
520 _a"Applied Pharmaceutical Practice and Nutraceuticals: Natural Product Developments showcases how pharmaceutical and nutraceutical compounds from natural products can be used to cure or prevent diseases. The chapters explore the connections between agrochemicals and pharmaceuticals and the use of plants and plant products in the formulation and development of new pharmaceuticals and nutraceuticals. The pharmaceutical industry recognizes the shift to the use of natural products while also considering the serious concerns that have arisen regarding the claimed efficacy, quality, and safety of these products. Chapters cover: The emerging perspectives of natural chalcone-based nitric acid inhibitors, the pharmacological properties of Emblicanin-A and Emblicanin-B constituents found in Phyllanthus emblica, the pathophysiology and various herbal drugs used for treating helminthiasis (or worm infections) and their pharmacological activities, natural medicines that can be employed as diuretics, the utilization, safety, and therapeutic perspectives of medicinal plant for treating psoriasis and skin diseases, the role of nutrients and cofactors, dietary adjustments and gut anomalies, probiotics and prebiotics, phytochemicals, and ecological factors for evaluating the condition of proof in nutraceutical-based disease management practices, beer as a major source of compounds associated with health benefits, which could possibly decrease the risks of cardiovascular disease, the role of the media as an important source of health information to help with personal medical decisions, specifically regarding cancer, the composition of Artemisia herba-alba and Origanum majorana essential oils is analyzed, and their antibacterial and antifungal activity, how medicinal plants and herbs combined with some kinds of alcohol develop healing, stimulating, and aphrodisiac effects while others can cause adverse effects and allergies."--
_cProvided by publisher.
588 _aOCLC-licensed vendor bibliographic record.
650 0 _aDrug development.
650 0 _aNatural products.
650 7 _aMEDICAL / Alternative Medicine
_2bisacsh
650 7 _aMEDICAL / Nutrition
_2bisacsh
650 7 _aMEDICAL / Pharmacology
_2bisacsh
700 1 _aMahapatra, Debarshi Kar,
_eeditor.
700 1 _aAguilar, Cristóbal Noé,
_eeditor.
700 1 _aHaghi, A. K.,
_eeditor.
856 4 0 _3Taylor & Francis
_uhttps://www.taylorfrancis.com/books/9781003054894
856 4 2 _3OCLC metadata license agreement
_uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
999 _c127696
_d127696